Also known as: 1970s Middle Eastern cannabis policy · Mechoulam's cannabinoid research in Israel

Medical Cannabis Advocacy in the Middle East During the 1970s

Legal prohibition and laboratory science, not organized patient advocacy, defined 1970s Middle Eastern cannabis.

Automated fact-check pass
6 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

The 1970s Middle East had no organized medical cannabis advocacy movement. What existed was strict prohibition, active hashish cultivation driven by Lebanon's civil war, and world-class laboratory science in Israel. Modern cannabis media sometimes projects today's activism backward, conflating Mechoulam's research with patient advocacy, war-economy cultivation with policy reform, and centuries-old folk use with medical legalization campaigns. This confusion obscures the real history.

By 1970, cannabis was illegal in virtually every Middle Eastern country. This prohibition was anchored in the 1961 UN Single Convention on Narcotic Drugs, which classified cannabis in Schedule IV — its most restrictive category [1] Strong evidence. Egypt had been a leading voice in cannabis prohibition since the 1920s, when its delegates successfully advocated for hashish to be added to the 1925 Geneva Convention's controlled-substances list [2] Strong evidence. That prohibitionist posture remained consistent throughout the 1970s across Arab states.

This legal environment left no room for organized medical advocacy. Medical cannabis as a policy question was not part of public debate in the region during the decade. Traditional cannabis and hashish use persisted in folk and Sufi traditions, but using a substance and campaigning for its medical legalization are distinct activities [6] Strong evidence.

The scientific story: Mechoulam's cannabinoid research

The most significant cannabis-related scientific work in the Middle East during the 1970s took place in a laboratory. Raphael Mechoulam and Yechiel Gaoni at the Weizmann Institute had isolated and characterized THC in 1964 [4] Strong evidence. During the 1970s, Mechoulam — then at Hebrew University of Jerusalem — continued structural and pharmacological studies of cannabinoids, including early investigations of cannabidiol (CBD) and epilepsy.

In 1980, Mechoulam's team published results from a small clinical trial testing CBD in patients with treatment-resistant epilepsy [5] Weak / limited. The study enrolled 8 patients on CBD and reported reduced seizure frequency in several participants. By modern standards, the trial was not blinded and was very small, but it represents one of the earliest controlled clinical investigations of a cannabinoid for a medical indication. The groundwork was laid in the late 1970s.

Mechoulam's role was primarily that of a research scientist documenting pharmacology and chemical structure, not that of a patient-access activist. He published peer-reviewed arguments that cannabinoids deserved serious pharmaceutical investigation [5] Strong evidence. This scientific contribution is distinct from organized medical advocacy.

Lebanon, hashish production, and the conflation problem

Lebanon's Bekaa Valley became one of the world's major hashish-producing regions during the 1970s, particularly after the Lebanese Civil War began in 1975 and central state authority collapsed in the region [3] Strong evidence. Contemporaneous reporting and later historical analyses describe this production as a war-economy phenomenon — a source of revenue in a fragmented state — rather than evidence of medical cannabis policy reform [3] Strong evidence.

This historical fact is sometimes retroactively framed as 'cannabis tolerance' or 'de facto legalization,' but no credible evidence shows organized medical cannabis advocacy from Lebanese growers, physicians, or patients during the 1970s. Lebanon remained legally prohibitionist throughout the decade. The country did not seriously revisit medical cannabis legislation until 2020, when parliament passed a law permitting cultivation for medical and industrial use Strong evidence. The gap between 1970s production and 2020 legislative change reflects that wartime cultivation and medical policy reform are not the same thing.

Egypt: prohibition and criminal enforcement

Egypt's approach to cannabis in the 1970s was overwhelmingly criminal-justice oriented. Historian Liat Kozma has documented that Egyptian authorities in the early 20th century framed hashish as a public health menace and a threat to productivity, and that prohibitionist framing persisted into the 1970s [2] Strong evidence. There is no credible historical record of an organized Egyptian medical cannabis movement during this decade. Traditional and recreational use existed; advocacy for medical reform did not.

Sources of modern myths about 1970s Middle Eastern advocacy

Contemporary cannabis media sometimes projects today's global medical advocacy framework backward, implying that 1970s Middle Eastern societies harbored organized medical reformers. This confusion arises from several conflations:

Mechoulam's research conflated with activism. He was a chemist and pharmacologist publishing structural and clinical results, not running a patient access campaign or political reform effort Strong evidence.

Bekaa Valley cultivation conflated with policy reform. The Bekaa's production boom was driven by civil war economics and state collapse, not by a deliberate medical or regulatory decision Strong evidence.

Traditional use conflated with medical advocacy. Sufi and folk traditions of hashish consumption span centuries [6] Strong evidence, but consuming a substance and campaigning for its legalization as medicine are distinct historical phenomena.

The organized medical cannabis advocacy movement — with patient testimonies, legislative campaigns, and medical societies — is largely a phenomenon that emerged in the United States in the 1990s, notably around California's Proposition 215 in 1996, and subsequently spread to other regions. Attributing it to 1970s Middle East is anachronistic.

What the evidence supports

Sources

How this page was made

Generation history

Oct 30, 2026
Fact-check pass — raised 9 flags
Oct 30, 2026
Revision
May 20, 2026
Fact-check pass — raised 2 flags
May 20, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.